Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.

Bocunebart's PACAP-targeting mechanism positions it as a potential first-in-class therapy in a thin pipeline of novel ...

Reasons to be Cheerful reports that cycling improves focus in kids, especially those with ADHD, as seen in Spooner Middle ...

A pre-wedding video showing Pune realtor Ketan Agarwal joyfully celebrating with his fiancée Siya Goyal and her parents has ...

A road repair program designed for holistic city reconstruction was called into question by councilors Monday at a public works committee meeting in council chambers, 50 Town Square, Lima. If ...

Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious underserved diseases, today announced ...

Don't buy a "borrowed science" NAD supplement. Discover how Niagen Bioscience’s patented NR safely and efficiently boosts ...

Beauty's next frontier isn't a product, it's brain health, with science-backed rituals reshaping skincare and a wellness ...

ATUM, a leading US-based contract research organization, selected to support stable clonal cell line generation to advance VERAXA’s lead BiTAC-TCE program toward IND/CTA-enabling activities ...

The U.S. Army veteran-operated maker of advanced photonic solutions will support U.S. Army's night fighting capability ...

The Social Security Administration announced it will issue commemorative cards for newborns through the end of the year. Here is what they look like. (Adobe Stock) ...

MANILA, Philippines — The Quezon City government and pharmaceutical company Boehringer Ingelheim (Philippines) Inc. have ...